Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × zanidatamab × Clear all

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms